Cell Signaling Technology

Phospho-Estrogen Receptor (Ser104/106) Antibody

#2517 · western blot

100
Citing papers
21.3k
Combined citations
Supplier page Find this product

Research areas

Pain Mechanisms and Treatments13PI3K/AKT/mTOR signaling in cancer11Cancer Immunotherapy and Biomarkers9Melanoma and MAPK Pathways7Cancer Cells and Metastasis7Protein Kinase Regulation and GTPase Signaling6Nerve injury and regeneration5NF-κB Signaling Pathways5

Papers citing this product

1
Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity
Nature·2020·1.2k cit.·DOI
2
Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment
Cell·2023·635 cit.·DOI
3
Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in <i>BRAF</i> <sup> <i>V600E</i> </sup> melanoma
Science Translational Medicine·2015·566 cit.·DOI
4
JNK-Induced MCP-1 Production in Spinal Cord Astrocytes Contributes to Central Sensitization and Neuropathic Pain
Journal of Neuroscience·2009·564 cit.·DOI
5
Phosphorylation of Mammalian Target of Rapamycin (mTOR) at Ser-2448 IsMediated by p70S6 Kinase
Journal of Biological Chemistry·2005·557 cit.·DOI
6
Tumor Necrosis Factor-α Induces Mechanical Allodynia after Spinal Nerve Ligation by Activation of p38 MAPK in Primary Sensory Neurons
Journal of Neuroscience·2003·521 cit.·DOI
7
A Peptide c-Jun N-Terminal Kinase (JNK) Inhibitor Blocks Mechanical Allodynia after Spinal Nerve Ligation: Respective Roles of JNK Activation in Primary Sensory Neurons and Spinal Astrocytes for Neuropathic Pain Development and Maintenance
Journal of Neuroscience·2006·519 cit.·DOI
8
Acute p38-Mediated Modulation of Tetrodotoxin-Resistant Sodium Channels in Mouse Sensory Neurons by Tumor Necrosis Factor-α
Journal of Neuroscience·2006·484 cit.·DOI
9
The Activation of MAPK in Melanoma Cells Resistant to BRAF Inhibition Promotes PD-L1 Expression That Is Reversible by MEK and PI3K Inhibition
Clinical Cancer Research·2012·470 cit.·DOI
10
EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy
Oncotarget·2014·386 cit.·DOI
Phospho-Estrogen Receptor (Ser104/106) Antibody — Evidence — PubIndex